Variation in PICU mortality by ethnicity and area-level deprivation highlights the importance of further investigation into ...

The correspondence of Joan B Soriano and Alberto Ruano-Ravina deserves timely praise, highlighting the threat that predatory ...

Public trust in scientific integrity is eroded by the politicisation of institutions under Donald Trump's US presidency. The implications extend far beyond American borders, striking at the core of ...

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

In 2025 the US Federal Government has attacked scientific research and evidence, medical expertise, public health, health equity, and human rights.1–5 At this challenging time, many health ...

The convergence of multiple crises—including the COVID-19 pandemic, geopolitical fragmentation, climate shocks, digital disruption, and economic precarity—has exposed the fragility and limitations of ...

Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

Negotiations are ongoing in New York to agree the latest UN political declaration on non-communicable diseases (NCDs) and ...

Growing interest in health and the exposome—a person's collective environmental exposures—is spurring new funding and research initiatives. Talha Burki reports.

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Level Meeting (HLM) on Noncommunicable Diseases and Mental Health (NCDs), which will be held on Sept 25, 2025 in New York, NY ...